Tayahop, Renita T.

HRN: 22-50-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2023
CEFTRIAXONE 1G (VIAL)
01/21/2023
01/27/2023
IV
2g
Q 24H
Lacerated Wound, Occipital Area
Waiting Final Action 
01/29/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/29/2023
02/04/2023
IV
1.5 Grams
Q 6 Hrs
Infected Wound
Waiting Final Action 
01/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/31/2023
02/07/2023
IV
4.5gram
Q6hrs
Septicemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: